Cytokine storm induced by a PD1 inhibitor in a renal transplant patient

被引：7

作者：

Del Bello, Arnaud ^{[1
]}

Zakaroff, Alexia G. ^{[2
]}

Meyer, Nicolas ^{[3
,4
]}

Delas, Audrey ^{[5
]}

Faguer, Stanislas ^{[1
,2
,7
]}

Kamar, Nassim ^{[1
,6
,7
]}

Belliere, Julie ^{[1
,2
,7
]}

机构：

[1] Univ Hosp Toulouse, Dept Nephrol & Organ Transplantat, Toulouse, France

[2] Hop Rangueil, Inst Metab & Cardiovasc Dis, INSERM, U1048,Team 12, Toulouse, France

[3] Toulouse Canc Inst IUC, Dept Oncodermatol, Toulouse, France

[4] CHU Toulouse, Univ Hosp, Toulouse, France

[5] Toulouse CHU, Toulouse Oncopole IUC, Dept Pathol, Toulouse, France

[6] Paul Sabatier Univ, Toulouse, France

[7] Toulouse Univ Hosp, INSERM, U1043, IFR BMT, Toulouse, France

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷 / 07期

关键词：

clinical research; practice; cytokines; cytokine receptors; immunosuppression; immune modulation; kidney transplantation; nephrology; macrophage; monocyte biology; activation;

D O I：

10.1111/ajt.16589

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：2616 / 2618

页数：3

共 8 条

[1] Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature [J].

Abdel-Wahab, Noha ;

Safa, Houssein ;

Abudayyeh, Ala ;

Johnson, Daniel H. ;

Van Anh Trinh ;

Zobniw, Chrystia M. ;

Lin, Heather ;

Wong, Michael K. ;

Abdelrahim, Maen ;

Gaber, A. Osama ;

Suarez-Almazor, Maria E. ;

Diab, Adi .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7

[2] Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review [J].

D'Izarny-Gargas, Thibaut ;

Durrbach, Antoine ;

Zaidan, Mohamad .

AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (09) :2457-2465

[3] Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19 [J].

Faguer, Stanislas ;

Del Bello, Arnaud ;

Abravanel, Florence ;

Nicolau-Travers, Marie-Laure ;

Kamar, Nassim .

ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) :501-+

[4] Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review [J].

Fisher, Juliya ;

Zeitouni, Nathalie ;

Fan, Weijia ;

Samie, Faramarz H. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) :1490-1500

[5] The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature [J].

Kumar, Vivek ;

Shinagare, Atul B. ;

Rennke, Helmut G. ;

Ghai, Sandeep ;

Lorch, Jochen H. ;

Ott, Patrick A. ;

Rahma, Osama E. .

ONCOLOGIST, 2020, 25 (06) :505-514

[6] Solid organ transplant rejection associated with immune-checkpoint inhibitors [J].

Saberianfar, S. ;

Nguyen, L. S. ;

Manouchehri, A. ;

Lebrun-Vignes, B. ;

Moslehi, J. J. ;

Johnson, D. B. ;

Hertig, A. ;

Salem, J. -E. .

ANNALS OF ONCOLOGY, 2020, 31 (04) :543-544

[7] Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade [J].

Stroud, Chipman R. G. ;

Hegde, Aparna ;

Cherry, Cynthia ;

Naqash, Abdul R. ;

Sharma, Nitika ;

Addepalli, Srikala ;

Cherukuri, Sulochana ;

Parent, Teresa ;

Hardin, Jessica ;

Walker, Paul .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) :551-557

[8] A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma [J].

Tsung, Irene ;

Worden, Francis P. ;

Fontana, Robert J. .

ONCOLOGIST, 2021, 26 (02) :133-138

← 1 →